Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

Press releases published on July 2, 2026

Jul. 2, 2026

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

Indeterminate GlobeNewswire

Jul. 2, 2026

Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Propanc Biopharma Initiates $5.0 Million Share Repurchase Program

Indeterminate GlobeNewswire

Jul. 2, 2026

NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel’s Potential in Alzheimer’s Disease and Other Neurodegenerative Conditions

Indeterminate GlobeNewswire

Jul. 2, 2026

OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Indeterminate GlobeNewswire

Jul. 2, 2026

Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

Indeterminate GlobeNewswire

Jul. 2, 2026

Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM

Indeterminate GlobeNewswire

Jul. 2, 2026

Burning Rock Announces Founder’s Purchase of Its ADSs

Indeterminate GlobeNewswire

Jul. 2, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Vireo Growth Inc. Announces Pennsylvania Dispensary License Transaction, Expanding into its 11th State

Indeterminate GlobeNewswire

Jul. 2, 2026

Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer

Indeterminate GlobeNewswire

Jul. 2, 2026

HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification

Indeterminate GlobeNewswire

Jul. 2, 2026

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

Indeterminate GlobeNewswire

Jul. 2, 2026

Anaveon Appoints Laetitia Pouzol as Chief Scientific Officer

Indeterminate GlobeNewswire

Jul. 2, 2026

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

Indeterminate GlobeNewswire

Jul. 2, 2026

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

Indeterminate GlobeNewswire

Jul. 2, 2026

Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering

Indeterminate GlobeNewswire

Jul. 2, 2026

Pep Club Launches Telehealth Platform Combining Prescription Therapy, Peptide Protocols, and At-Home Biomarker Testing

Indeterminate GlobeNewswire